Programme update
The Spring booster campaign will start on Monday 3 April 2023 with residents in care homes for older people and other eligible groups starting on Monday 17 April 2023.
The Spring booster dose will be offered to:
- Everyone aged 75 and over
- Residents in care homes for older adults
- People aged five and over who are immunosuppressed
What vaccine will I be offered?
You will be given a booster dose of a vaccine made by Pfizer, Moderna or Sanofi and approved in the UK. These vaccines have been updated since the original vaccines and target different COVID-19 variants.
For a very small number of people another vaccine product may be advised by your doctor.
These updated vaccines boost protection well, and give slightly higher levels of antibody against the more recent strains of COVID-19 (Omicron) than the vaccines you would have received previously.
As we cannot predict which variants of COVID-19 will be circulating this spring and summer, the Joint Committee on Vaccination and Immunisation (JCVI) have concluded that all of these vaccines can be used and that no one should delay vaccination to receive a different vaccine.
Authorised vaccines and patient information leaflet (PIL)
Spikevax vaccine
Spikevax Original/Bivalent BA.1
(50 micrograms/50 micrograms)/mL dispersion for injection
elasomeran/imelasomeran
Updated March 2023
Spikevax Original/Omicron BA.4-5
(25 micrograms/25 micrograms dispersion for injection)
elasomeran/davesomeran
Updated February 2023
Comirnaty
Comirnaty original/Bivalent BA.1 (15/15 micrograms)/dose dispersion for injection
Adults and adolescents from 12 years
COVID-19 mRNA Vaccine (nucleoside modified)
Comirnaty 3 micrograms/dose concentrate for dispersion for injection
Infants and children 6 months to 4 years COVID-19 mRNA Vaccine (nucleoside modified)
Updated March 2023
Comirnaty 30 Adults and adolescents from 12 years micrograms/dose concentrate for dispersion for injection Adults and adolescents from 12 years COVID-19 mRNA Vaccine (nucleoside modified)
Updated March 2023
Comirnaty 10 Concentrate micrograms/dose concentrate for dispersion for injection
Children 5 to 11 years COVID-19 mRNA Vaccine (nucleoside modified)
Updated March 2023
Nuvaxovid
Last updated 11/2022 - Product Information Leaflet (PIL) for Nuvaxovid dispersion for injection
Updated November 2022
Consent
In order to be vaccinated you must be able to demonstrate informed consent at your appointment. If you believe your loved one does not have the capacity to consent in their own right, they will need a Best Interest Consent form to be completed by their General Practitioner and brought to the appointment.